Related Experiment Video
Updated: Jul 13, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Fertility preservation in female cancer survivors
1Royal Free and University College Medical School, London, UK. jaskerwei@gmail.com
Abstract:
The advancement of cancer therapies over the last few decades has significantly improved long-term survival of cancer patients, especially children and adolescents. As many of the therapeutic agents used are highly cytotoxic, cancer survivors have to pay the price of enduring various immediate and long-term side-effects. Unfortunately, gonadal failure and infertility are among the most common long-term side-effects, resulting in distress, lowered self-esteem and quality of life. Three modalities of fertility preservation can be offered to female patients prior to commencing their cancer treatment: embryo, oocyte and ovarian tissue cryopreservation. This paper reviews the outcomes for female patients who underwent fertility preservation in University College Hospital between 1995 and 2005, and post-therapeutic use of their frozen specimens. In addition, the effects of cytotoxic agents on fertility and ovarian function, and the range of fertility preservation available for female cancer sufferers are also discussed.
Related Concept Videos
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Infertility in Males
Cancer Prevention
Some...
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Survival Analysis

